BioCentury
ARTICLE | Management Tracks

Siga names Diem Nguyen CEO

Plus: Fish & Richardson names Sawert as principal and updates from ImmunoBrain and DiaMedica

January 23, 2024 1:48 AM UTC

Siga Technologies Inc. (NASDAQ:SIGA) named Diem Nguyen to succeed Phil Gomez as CEO, effective Jan. 27. Nguyen was CEO of Xalud Therapeutics Inc. and served as EVP of biopharma at PPD Inc.; Gomez is retiring on Jan. 26. 

IP law firm Fish & Richardson named Kristi Sawert as a principal in their post-grant practice representing life sciences clients. Sawert, a former U.S. Patent Trial and Appeal Board administrative patent judge, has more than 20 years of patent law experience, with most of that at PTAB, the U.S. Patent and Trademark Office’s Solicitor’s Office, and the U.S. Court of Appeals for the Federal Circuit...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article